Delivery Order SPE2DB20D3101-SPE2DB24FRRS6
Award Date
8/6/24
Potential Completion Date
8/7/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The order is for Xifaxan 550 mg tablets and has a ceiling value of $12,553.49. The contract is a firm fixed-price delivery order with a completion date of December 21, 2023. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Xifaxan 550 mg tablets. The contract has a firm fixed price, with a ceiling value of $37,140.56, and an ultimate completion date of September 10, 2024. The contract is a delivery order and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Xifaxan 550 mg tablets. The contract has a ceiling value of $4,050.50 and is a firm fixed price delivery order with a completion date of November 14, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $10,087.24 firm fixed-price contract provides the DLA with 4,563,517,205 units of the drug Xifaxan 550 mg tablets. The contract has a completion date of February 2, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Xifaxan 550 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,759.13 and a period of performance through May 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Xifaxan 550 mg tablets, a prescription medication used to treat certain gastrointestinal conditions. The total ceiling value of the contract is $3,591.66, with an ultimate completion date of April 26, 2023. The contract is not designated as a set-aside award....
This federal contract award, valued at $7,409.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Xifaxan 550 mg tablets, a medication used to treat certain gastrointestinal conditions. This is a firm fixed-price delivery order contract with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xifaxan 550 mg tablet 60s, a prescription medication. The contract has a ceiling value of $11,293.08 and is a firm fixed price delivery order. The ultimate completion date is June 10, 2025. This contract is not designated as a set-aside and is open to full and open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Xifaxan 550 mg tablets. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) with a ceiling value of $5,274.15. The order has a period of performance through September 13, 2024, with an award date of September 12, 2024. There is no set-aside designation indicated. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,271.54, is for the delivery of Xifaxan 550 mg tablets. The contract has a period of performance through November 20, 2024 and utilizes a firm fixed price pricing structure. This award is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...